Mirion Technologies
MIR | NYSE
$17.04
-$0.70 (-3.95%)
At close: Nov 16, 2026, 4:00 PM ET
$17.08
+$0.04 (+0.23%)
After-hours:
Nov 16, 2026, 7:58 PM ET
Mirion Technologies Company Profile
Company profile explainedCompany Profile
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Key Executives
| Name | Position |
|---|---|
| Thomas D. Logan | Founder, Medical Group President, Chief Executive Officer & Chairman |
| Emmanuelle Lee | Executive VP, Chief Legal Officer, Chief Compliance Officer & Secretary |
| James Francis Charles Cocks | Chief Technology Officer |
| Marc Rubel | Chief Information Officer |
| Alison Ulrich | Chief Human Resources Officer |
| Brian Schopfer | CFO & Medical Group President |
| Christopher Moore | Chief Accounting Officer |
| Eric Linn | Vice President of Investor Relations |
| Erin Schesny | CMO & Senior Vice President of Government Affairs |
| Loic Eloy | Group President of Nuclear & Safety Technologies |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 10-Q | Quarterly Report |
| Oct 27, 2026 | 8-K | Current Report |
| Sep 30, 2026 | 4 | Filing |
| Sep 30, 2026 | 4 | Filing |
| Sep 02, 2026 | 4 | Filing |
| Aug 31, 2026 | 8-K | Current Report |
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 28, 2026 | 8-K | Current Report |
| Jul 02, 2026 | 8-K | Current Report |
| Jun 30, 2026 | 4 | Filing |
Mirion Technologies
| Country | United States |
| IPO Date | Aug 20, 2020 |
| Industry | Industrial - Machinery |
| Sector | Industrials |
| Employees | 3,281 |
| CEO | Thomas D. Logan |
Contact Details
1218 Menlo Drive Atlanta,
Georgia 30318 United States
Stock Details
| Ticker Symbol | MIR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001809987 |
| CUSIP Number | 60471A101 |
| ISIN Number | US60471A1016 |
| SIC Code | 3829 |
Recent News
- 8 days ago / businesswire.comMirion to Present at Baird's 2026 Global Industrial Conference
- 19 days ago / seekingalpha.comMirion Technologies, Inc. (MIR) Q3 2026 Earnings Call Transcript
- 19 days ago / marketbeat.comWhat Mirion Technologies (MIR) Said on Its Q3 Earnings Call
- 20 days ago / zacks.comMirion Technologies (MIR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- 20 days ago / zacks.comMirion Technologies, Inc. (MIR) Matches Q3 Earnings Estimates
- 20 days ago / businesswire.comMirion Announces Third Quarter 2026 Financial Results
- 27 days ago / businesswire.comMirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
- 28 days ago / zacks.comMirion Technologies, Inc. (MIR) Reports Next Week: What You Should Expect
- 1 month ago / businesswire.comMirion Announces Earnings Release and Conference Call Date for Third Quarter 2026
- 1 month ago / gurufocus.comA Look at Mirion Technologies Inc (MIR) After 3.2% Decline -- GF Value $15.60 vs Price $15.90
Add to Watchlist
Select watchlists to add or remove MIR